blog
Patrick Oliver
IP2I shares feedback on the Commission’s roadmap for the IP Action Plan
IP2Innovate has responded to the request for feedback on the upcoming European Commission’s Intellectual Property Action Plan.
We share the Commission’s view that “well-calibrated and balanced IP policies can […] boost Europe’s industrial competitiveness” and get the EU back “on track towards economic recovery” from the Covid-19 outbreak crisis. We applaud, in particular, the Commission’s commitment in the roadmap to “continue to monitor the application of the IPR Enforcement Directive to ensure it is effective and balanced, particularly on injunctions.”
To see our response click here.
Share
Other press releases
IP2Innovate
IP2Innovate calls on the European Commission to strengthen EU law to ensure a balanced patent system and enhance Europe’s competitiveness
BRUSSELS, 25 March 2024 - IP2Innovate is calling for targeted amendments to EU intellectual property law to ensure that European patent courts consider the proportionality of remedies in their handling of patent litigation cases.
The proposed amendments will help create a more balanced patent system. This will spur innovation and, in turn, help to address Europe’s lagging competitiveness.
The 2004 EU IP Rights Enforcement Directive (IPRED) requires that remedies for patent infringement be applied in a proportionate manner, but courts are handing out injunctions to patent owners in effect automatically, without considering the disproportionate impact that may result.
handelsblatt.com
Ministerin Lambrecht will rigider gegen „Patenttrolle“ vorgehen
Die Bundesjustizministerin will das Patentrecht modernisieren – und zwar stärker als noch in einem ersten Diskussionsentwurf angekündigt.
Industriekoalition IP2Innovate fordert Patentrechtsreform zur Förderung von Innovation in Deutschland
Das Patentrecht ist ein wesentlicher Eckpfeiler für Innovation und – damit verbunden – für nachhaltiges Wirtschaftswachstum. Es kann dieser Rolle allerdings nur gerecht werden, wenn es die Entwicklung und das Inverkehrbringen komplexer, multifunktionaler Hightech-Produkte wie Autos, Telefone und medizinische Geräte unterstützt. Dies tut das deutsche Patentrecht derzeit nicht! Hauptmangel: Unterlassungsklagen werden automatisch erlassen, ohne alternative, geeignetere Rechtsmittel zu prüfen. Diese Situation schadet der deutschen Industrie.